Clinical Program Leader (CPL)

Novartis; Cambridge (MA); Hybrid; USD 249,000 - 462,000; Full time

Job summary

Novartis in Cambridge, MA is seeking a Senior Clinical Pharmacology Leader (CPL) to provide strategic medical guidance for preclinical to transition decision point programs in oncology. The role is hybrid with onsite preference for local candidates. Level depends on skills and interview outcomes.

The CPL will lead development strategies, integrate preclinical data, and ensure alignment with regulatory requirements and SOPs. Global collaboration and mentorship are expected.

Qualifications

• MD or DO degree required.
• Board-certification in oncology preferred; PhD-level science a plus.
• Fluent English – oral and written.

Responsibilities

• Provide strategic medical leadership to oncology development programs.
• Develop clinical development strategies across PE/DC to TDP.
• Lead cross-functional teams and global project leadership.
• Ensure compliance with GCP and Novartis SOPs.
• Mentor junior CPLs and liaise with external experts.

Skills

Strategic medical leadership

Senior/cross-functional leadership

GCP knowledge

Medical writing

Office IT skills

Education

MD or DO degree

Oncology board-certification

PhD-level science

Tools

GCP tools

Job description

Summary

Location: Cambridge, MA. Hybrid
May consider DWA, but candidates local to onsite preferred
Experience will determine which level 6 (Senior CPL or CPL) is appropriate after interview process based on skills and experience.
CPL: Provides strategic medical guidance and leads the development of experimental oncology agents in the TCO portfolio, beginning with PE / DC (Portfolio Entry / Drug Candidate) of preclinical development and continuing through TDP (Transition Decision Point).

About The Role

Major Accountabilities

• Provides strategic medical and scientific leadership and expertise to all line functions on the project team for the development of new oncology agents (e.g., small molecules, biologics, radioligand therapies) that are in preclinical development, typically beginning at the PE / DC
• Creates clinical development strategies for new oncology agents within the PE/ DC to TDP timeframe. The development strategy combines the CPL’s medical knowledge with the expertise of colleagues in a wide range of other disciplines (e.g., Clinical Pharmacology, Biostatistics) to optimize the clinical development strategy. Delivers solutions within functions, across functions, and on global projects, developing independent approach to TCO strategy.
• Although registration studies are not within the responsibility of TCO, the CPL must provide an early clinical development strategy that foresees and supports subsequent registration trials. Development of the Integrated Development Plan Approval (IDPA) in alignment with CPL Disease Area Leads (DALs), Development (DEV), Strategy & Growth (S&G), and Commercial teams
• Lead Biomedical Research Early Program Teams (BPTs) to enable the start of clinical development and continuing through clinical trials needed to support TDP. May lead multiple global project teams
• Integrates preclinical information (pharmacology, toxicology, and pharmacokinetics) and interprets implications for clinical development, as articulated in the Investigator’s Brochure and First-in-Human protocol
• Collaborates with clinical scientists to develop clinical protocols for TCO compounds and develop the instruments needed to implement, interpret and report them (e.g., case report forms, report and analysis plans, clinical study reports)
• Applies own medical knowledge to guide the safe, ethical and efficient conduct of the trials under own responsibility. Knowledgeable in Good Clinical Practice guidelines and Novartis Standard Operating Procedures and strives to maintain compliance with them
• Liaises with outside experts, investigators, and regulatory authorities in oncology, and represents own projects to those groups and authorities
• Writes and reviews abstracts/manuscripts etc. for presentation/publications at internal/external meetings
• Participates in task forces to support continuous improvement and other management objectives. Operational responsibility for quality and compliance
• May provide informal mentorship to less experienced CPLs

Qualifications

Education:

MD or DO degree

Board-certification in an oncology specialty and PhD-level science are preferred

Languages

Fluent English – Oral and written

Experience/Professional Requirement

• At least 2 years of pharmaceutical/biotech industry experience in oncology clinical trials plus the equivalent duration experience from an academic medical center. If limited or no Pharmaceutical industry experience, then comparable senior academic experience in translational oncology and clinical research
• Recognized as an expert in your field by external medical experts. External candidates have a substantial record of publication and international recognition
• Excellent interpretation of oncology preclinical data (molecular biology, pharmacology, pharmacokinetics, and toxicology)
• Strong knowledge of the application of PK/PD and biostatistics to clinical development and clinical trials
• Proven ability to analyze and interpret efficacy and safety data relating to oncology
• Knowledge of GCP and world-wide regulatory requirements for clinical trials and oncology
• Excellent medical/scientific writing skills
• Successful track record of strategic thinking
• Proven ability to develop and inspire project/line/matrix multidisciplinary teams in a global environment
• Excellent personal ethical integrity and a commitment to improving the outcomes for patients with malignancies
• Excellent written and oral English communication/presentation skills
• Strong office IT skills

Novartis Compensation And Benefit Summary

The salary for this position is expected to range between $248,500.00 - 461,500.00 USD Annual per year.

The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors.

• Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards.
• US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.

Why Novartis:

Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture

Benefits and Rewards:

Learn about all the ways we’ll help you thrive personally and professionally.

Read our handbook (PDF 30 MB)

EEO Statement

The Novartis Group of Companies are Equal Opportunity Employers. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, sex, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status.

Accessibility & Reasonable Accommodations

The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or to perform the essential functions of a position, please send an e-mail to [email protected] or call [phone] and let us know the nature of your request and your contact information. Please include the job requisition number in your message.